Dahlquist Karl S. 4
4 · AtriCure, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
AtriCure (ATRC) Chief Legal Officer Karl Dahlquist Buys Stock
What Happened
Karl S. Dahlquist, Chief Legal Officer of AtriCure, acquired 636 shares of AtriCure common stock on June 30, 2026. The shares were purchased under AtriCure’s 2018 Employee Stock Purchase Plan (ESPP) at $23.78 per share, for a total acquisition value of $15,124. This is a purchase (acquisition) rather than a sale.
Key Details
- Transaction date: 2026-06-30; filing date: 2026-07-02 (no indication in the filing that it was late).
- Shares acquired: 636 at $23.78 each; total value $15,124.
- Purchase mechanism: AtriCure 2018 ESPP for the offering period ended June 30, 2026 (per footnote).
- Price basis: ESPP price = 85% of the closing price on 6/30/2026; closing price that day was $27.98, producing the $23.78 purchase price.
- Shares owned after the transaction: Not disclosed in this filing.
Context
ESPP purchases use payroll contributions and often include a discount (here, 85% of the period-end price), so they are routine employee purchases rather than open-market buys. Such purchases can indicate insider participation but are common for employees using company benefit plans and do not by themselves indicate future company performance.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-30$23.78/sh+636$15,124→ 96,689 total
Footnotes (2)
- [F1]Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.